"e-Zyvec, a supplier of molecular tools for genetic engineering, has received a significant investment from another European biotechnology company, which is acquiring a minority stake in the company.
This investment will contribute to the commercial development of eZyvec's innovative services: the customization (design and production) of DNA vectors, or plasmids. Bpifrance also participated in this round of financing, which totaled €1.4 million.